Filing Details
- Accession Number:
- 0001127602-11-006424
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-18 17:35:13
- Reporting Period:
- 2011-02-17
- Filing Date:
- 2011-02-18
- Accepted Time:
- 2011-02-18 17:35:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1016369 | D Leonard Schaeffer | 2525 Dupont Drive Irvine CA 92612 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-02-17 | 9,000 | $51.72 | 13,800 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-02-17 | 9,000 | $75.00 | 4,800 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2011-02-17 | 9,000 | $0.00 | 9,000 | $51.72 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-05-02 | 2016-05-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 51,266 | Indirect | By Family Trust |
Footnotes
- Shares held by the Schaeffer Revocable Family Trust dated 10/02/97 established by reporting person as co-settler for the benefit of self and others.